StrokeSHAPER-SONCT04864470
Stroke Odysseys: Evaluation of a Community-based Performance Arts Programme for People That Have Experienced Stroke
A study testing Stroke Odysseys in people with Stroke, run by King's College London at 1 site in United Kingdom.
Trial summary
There are over 1.2 million stroke survivors in the UK and annual costs of stroke care to the NHS will treble from £3.4 billion in 2015 to £10.2 billion in 2035. More than 60% of stroke survivors leave hospital with a disability, and half experience depression within the first five years. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke
- What is being tested?
- Stroke Odysseys
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 122 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Sep 2021to 1 Nov 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- over 18 years of age
- have had one or more stroke(s)
- received inpatient care in a UK stroke care pathway and are able to follow a 2-stage command and hold a conversation in English if no supporter/friend is available to translate
Who cannot join
- any person with co-morbidities that would prevent participation in group activities e.g. dementia or deteriorating or fluctuating palliative conditions
- unable to understand English
- unable to commit to the 12-week programme
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site, 1 recruiting
- Recruiting
Institute of Psychiatry, Psychology & Neuroscience
London, SE5 8AB
Rachel Davis, PhD, +44 (0) 20 7848 0780, rachel.davis@kcl.ac.uk
Carolina Estevao, PhD, +44 (0) 20 7848 0780, carolina.estevao@kcl.ac.uk
About this study
There are over 1.2 million stroke survivors in the UK and annual costs of stroke care to the NHS will treble from £3.4 billion in 2015 to £10.2 billion in 2035. More than 60% of stroke survivors leave hospital with a disability, and half experience depression within the first five years. Emotional, social and psychological needs are common, often compounded by patients' perceptions of 'abandonment' when rehabilitation ends.
Currently there is a gap between the social, emotional and physical needs of stroke survivors and the availability and suitability of long-term recovery and rehabilitation services. In 2018, a commissioned survey by the Stroke Association found 50% of stroke survivors and 85% of carers felt they needed more support than currently exists.
Read more
Stroke Odysseys - the performance art programme- provides an opportunity for communication of experiences of stroke to an audience through acquired skills in movement, music, song and the spoken word. The performance arts courses delivered by Rosetta Life for stroke survivors have been evaluated in previous studies and have shown that engagement in and learning about performance skills can have a positive impact on perceptions of disability, improve cognition, mobility and speech disabilities among a stroke community that can be stigmatised by the public perception of disabling illness.
The Stroke Odysseys programme will be scaled up to a large number of participants with the aim to evaluate the experience, impact and implementation of the programme. This prospective study will evaluate the experience and impact of Stroke Odysseys on those participating using mixed methods (interviews, observations and surveys) prior to and after each stage of the programme, and carry out non-participant observations during a percentage of the workshops, training and tour.
This trial will also examine how effectively the programme is implemented and the factors (facilitators or barriers) that affect its implementation (i.e. implementation effectiveness). This will help us to identify not just 'if' but also 'why' the programme works and support our understanding of how it can be successfully delivered and scaled up within clinical pathways. Within this, the researchers will also explore the cost effectiveness of the programme, including the cost of its delivery and the balance of the benefit for the health sector, in order to be able to develop strong business plan for its longer-term use and wider scale implementation.
Read the detailed description
There are over 1.2 million stroke survivors in the UK and annual costs of stroke care to the NHS will treble from £3.4 billion in 2015 to £10.2 billion in 2035. More than 60% of stroke survivors leave hospital with a disability, and half experience depression within the first five years. Emotional, social and psychological needs are common, often compounded by patients' perceptions of 'abandonment' when rehabilitation ends. The impact also extends to family caregivers who experience higher rates of depression than the general population. This issue is a clear research finding expressed in numerous systematic reviews, including a meta-review by Pearce et al 2015. The review team highlighted: "The devastating impact of stroke on patients' self-image; the varying needs for self-management support across the trajectory of recovery; the need for psychological and emotional support throughout recovery particularly when physical recovery plateaus; the considerable information needs of patients and carers which also vary across the trajectory of recovery; the importance of good patient-professional communication; the potential benefits of goal-setting and action-planning; and the need for social support which might be met by groups for stroke survivors".
Currently there is a gap between the social, emotional and physical needs of stroke survivors and the availability and suitability of long-term recovery and rehabilitation services. In 2018, a commissioned survey by the Stroke Association also confirmed the devastating impact of stroke on the lives of individuals and their carers. Responses from more than 11,000 stroke survivors and carers showed a range of 'hidden effects', which do not necessarily disappear with time, and in many cases, can be life-long. Most common were the effect on emotional and mental health, cognition, confidence, finances, social life and relationships. The survey findings also showed 50% of stroke survivors and 85% of carers felt they needed more support than currently exists.
Stroke Odysseys - the performance art programme- provides an opportunity for communication of experiences of stroke to an audience through acquired skills in movement, music, song and the spoken word. The Stroke Odysseys approach has been developed over a number of years and is facilitated by the charity Rosetta Life, with a track record of in hospital, hospice and community-based performance arts projects. This program aims to address the sense of abandonment and social isolation experienced by stroke survivors after statutory care (community rehabilitation) is completed. The performance arts courses delivered by Rosetta Life for stroke survivors have been evaluated in previous studies and have shown that engagement in and learning about performance skills can have a positive impact on perceptions of disability, improve cognition, mobility and speech disabilities among a stroke community that can be stigmatised by the public perception of disabling illness.
Trial design and aims: The Stroke Odysseys programme will be scaled up to a large number of participants with the aim to evaluate the experience, impact and implementation of the programme. Evaluation will take place across community settings in South London and involve stroke participants and the wider stakeholder community.
Stroke Odysseys comprises three distinct stages:
- weekly workshops over 12 weeks for stroke participants facilitated by an integrated team of expert artists and ambassadors from the charity Rosetta Life
- a smaller group of ambassadors recruited from the workshops will be trained to become co-facilitators (stroke ambassadors)
- a performance tour including education and taster workshops for audiences.
The project will evaluate the experience and impact of Stroke Odysseys on those participating using mixed methods (interviews, observations and surveys) prior to and after each stage, and carry out non-participant observations during a percentage of the workshops, training and tour.
Pandemic (COVID-19) Response: Depending on government guidelines on social distancing and foreseeing increased anxiety in stroke survivors to attend in-person sessions, the programme stages will be delivered using a blended approach of small in-person sessions and online live-streamed sessions. Participants will self-select, according to their willingness to travel and to meet socially with others. Those who choose to come to a studio will be invited to do so and those who choose to join from home will participate online. A researcher will manage groups to ensure that all the participants that wish to attend in person will be able to do so during the 12-weeks.
This is a prospective mixed methods study using a range of qualitative and quantitative methods at different time points pre, during and post implementation of each programme cycle. The research will want to understand the impact of Stroke Odysseys on improving patients' symptoms and their emotional wellbeing i.e.the effectiveness of the programme (i.e. intervention effectiveness). Additionally, and simultaneously, to examine how effectively the programme is implemented and the factors (facilitators or barriers) that affect its implementation (i.e. implementation effectiveness). This will help us to identify not just 'if' but also 'why' the programme works and support our understanding of how it can be successfully delivered and scaled up within clinical pathways. Within this, the research will also explore the cost effectiveness of the programme, including the cost of its delivery and the balance of the benefit for the health sector, in order to be able to develop strong business plan for its longer-term use and wider scale implementation.
An ethnographic and constructivist approach will be used to examine stroke survivors' experiences of the SO programme as it provides rich, holistic insights into people's views and actions, as well as the nature of the location (context) they inhabit, and this approach aligns well with the complex nature of the Stroke Odysseys programme.
Participants and Recruitment process: 75 new stroke survivors in total for the duration of the study. Based on previous experience of running Stroke Odysseys, a drop-out rate of 20% is expected and so the final number of ambassadors is estimated to be 60. Potential stroke survivor participants will be identified through signposting in community centres, care homes and the engagement offered through the presentations and screenings and taster sessions and performances from the performance tour. In response to the current pandemic, all recruitment will be delivered online.
In addition, a group of wider stakeholders will be recruited from the network of people involved in the referral, delivery or supporting of the programme. The wider stakeholders will be recruited from the network of people involved in the programme present in community. This includes the voluntary sector, health and social care sectors and clinical commissioners. A total of 47 stakeholders will be recruited for the stakeholder group.
Measures collected: There will be at 4 time points for data collection, run in two cycles in total (i.e. we will collect data twice at each timepoint, once for cycle one and then again for cycle 2).
T0 - Baseline pre-performance programme,
T1 - Midway through the programme
T2 - Immediately post performance
T3 - Immediately after the advocacy training for ambassadors
To maximise inclusivity and outcome completion, and to minimise participant burden, outcome assessments, where possible will be conducted either face-to-face, online, by telephone or via postal questionnaire depending on the outcome measures being assessed and participants preferences (and government COVID-19 guidelines).
To measure clinical outcomes, a mixture of qualitative and quantitative measures will be used:
Qualitative assessments (ethnographic research) Ethnographic non-participant observations of a selection of the 12 workshops including at least 1-2 groups from each of the two phases (building confidence, rehearsal and production) to capture facilitator and participant practice, interactions and routines. Each observation period will last for the duration of the workshop, and the researcher will record field-notes contemporaneously.
Implementation outcomes will also be assessed using a mixture of quantitative and qualitative measures.
Validated and standardised implementation scales will be used to gather quantitative data on how acceptable, appropriate and feasible the SO programme is perceived by stroke survivors, ambassadors, deliverers, supporters and referrers. These scales include:
- Acceptability of Intervention Measure (AIM): this is a 4-item scale that assesses how agreeable the programme is to participants.
- Intervention Appropriateness Measure (IAM): this is a 4-item scale that assesses how suitable participants find the programme.
- Feasibility of Intervention Measure (FIM): this is a 4-item scale that assesses how feasible to receive/deliver participants find the programme.
All 3 scales will be administered to the stroke survivors who have enrolled in the SO programme and given their consent for data collection (anticipated number = 75 participants) at 3 time points (T1-midway through the 12-week SO programme); T2 at the end of the SO programme; T3 at the end of the 4-week stroke ambassadors training). The researchers expect a drop-out rate of 20% for participants between stage one (12-week programme) and stage two (4-week ambassador training programme) which would leave approximately 60 participants completing the questionnaires at the end of stage two (T3). The investigators will also administer the scales to the wider stakeholder group comprising supporters, deliverers and referrers at timepoints T2 and T3 (approximately 20 participants in total).
The investigators also will conduct semi-structured interviews with a purposive sub-sample of stroke survivors (N= 20: 5 from each cycle at two time points - T2 and T3) to explore their attitudes towards the acceptability, appropriateness and feasibility of the programme, as well as factors (facilitators or barriers) that affected their involvement (and potential drop-out) and any unintended consequences. The research team will also explore these issues with a sub-sample of individuals from each of the wider stakeholder groups (10 in total). Views from individuals that are part of the wider stakeholder group will also be sought on factors that could affect the sustained use of the programme and strategies that were employed to implement the programme.
- Conditions
- Stroke
- Being tested
- Stroke Odysseys
- Keywords
- Stroke, Health-arts intervention, Performing arts
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stroke OdysseysBehavioural
The participants will take part in a twelve-week performance programme that takes place online/in a community halls/arts centre. Sessions run for three hours and during these sessions, participants devise a dance and music performance work from their own stories. The culmination of the programme will be a public facing performance to an audience of carers, health care practitioners, friends, family and the wider community, done online through Zoom.
After the performance is completed, participants will be invited to a training programme where they learn to act as advocates for life after stroke - termed 'stroke ambassadors'. The training will be a four-day programme. The programme will take place once weekly and is led by a team of artists supported by a leadership coach, on Zoom.
Following training, ambassadors will support artists in recruitment, befriend the newly discharged stroke survivors and take part in small scale performance tours to challenge the perception of disability.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Stroke Odysseys is a performing arts intervention for people who have had strokes which provides an opportunity for communication of experiences of stroke to an audience through acquired skills in movement, music, song and the spoken word.
Stroke Odysseys comprises three distinct stages:
1. weekly workshops over 12 weeks for stroke participants facilitated by an integrated team of expert artists and ambassadors from the charity Rosetta Life
2. a smaller group of ambassadors recruited from the workshops will be trained to become co-facilitators (stroke ambassadors)
3. a performance tour including education and taster workshops for audiences. Receives: Behavioral: Stroke Odysseys |
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate emotional wellbeing, participation and activity of stroke participants and any change pre and post SO programme using qualitative methods
To evaluate emotional wellbeing, participation and activity of stroke participants and any change pre and post intervention - ethnographic research and interviews
Measured: The primary clinical outcome are qualitative changes in emotional wellbeing, participation and activity of stroke participants pre and post intervention (after 16 weeks)
To evaluate to what extent Stroke Odysseys is acceptable, to survivors and wider stakeholders using the Acceptability of Intervention Measure (AIM)
The primary outcome implementation measure is acceptability as measured by the Acceptability of Intervention Measure (AIM) A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean.
Measured: The AIM will be collected during the workshop (Week 6), after the workshop is completed (Week 12) and after stroke ambassador training (Week 16). Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16).
To evaluate to what extent Stroke Odysseys is acceptable, to survivors and wider stakeholders using semi-structured interviews.
The primary outcome implementation measure is acceptability as measured by semi-structured interviews to explore reasons for acceptability.
Measured: Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16).
Secondary outcomes (12)
To study the context, mechanisms and interactions which take place during Stroke Odysseys delivery
Non-participant observations of workshops
Measured: During workshop delivery (Week 6)
To explore learning and experiences of facilitators and participants
Semi-structured interviews (stroke participants and facilitators)
Measured: After the workshop is completed (Week 12)
To explore stroke survivors' preparation and participation in performances
Semi structured interviews (stroke participants)
Measured: Baseline
To evaluate to what extent Stroke Odysseys is appropriate to survivors and wider stakeholders
Intervention Appropriateness Measure (IAM) \& Semi-structured interviews to explore reasons for appropriateness score.
The A 4-item measure of perceived intervention appropriateness. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean.
Measured: The IAM will be collected during the workshop (Week 6), after the workshop is completed (Week 12) and after stroke ambassador training (Week 16). Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16)..
To evaluate to what extent Stroke Odysseys feasible to survivors and wider stakeholders
Feasibility Intervention Measure (FIM) \& Semi-structured interviews to explore reasons for feasibility score The FIM is a 4-item instrument to assess perceived intervention feasibility. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean
Measured: The FIM will be collected during the workshop (Week 6), after the workshop is completed (Week 12) and after stroke ambassador training (Week 16). Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16).
To assess any unintended consequences of the programme
Semi-structured interviews
Measured: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To explore the facilitators and barriers to implementing the programme
Semi-structured interviews
Measured: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To explore the facilitators and barriers to sustained use of the programme
Semi-structured interviews
Measured: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To assess service utilisation and cost associated costs and changes in quality of life associated with the implementation of the programme
EQ5D-5L (quality of life measure) and AD-SUS (adult service receipt schedule) and semi structured interviews and activity data (to estimate implementation costs).
The EQ5D-5L is an instrument which evaluates the generic quality of life developed in Europe and widely used. The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
The AD-SUS measures the use of adult health services.
Measured: These measures will be collected after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To explore the strategies including resource inputs utilised, used within individual sites to implement the programme
Semi-structured interviews
Measured: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To assess the adoption of the programme
Count the number of individuals delivering the programme, and the number of individuals supporting the programme (and continuing to do so)
Measured: This will be measured at baseline, after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To assess programme adherence and attrition rates
Data on the overall adherence to the programme, number of drops-outs and reasons why
Measured: Data recorded from register on weekly attendance rates for 12-week programme (stage 1) and for 4-week ambassador programme (stage 2)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Apr 2021
- Study start1 Sep 2021
- Primary completion1 Nov 2022 (estimated)
- Study completion1 Nov 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by King's College LondonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 122 participants (estimated)
Sponsor and investigators
- Lead sponsor
- King's College London
- Sponsor type
- University, hospital or other
- Collaborators
- Rosetta Life, Kingston University and St George's
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04864470
- Sponsor's protocol ID
- 219425/Z/19/Z-SO
- Acronym
- SHAPER-SO
- Status last verified
- Aug 2022
- First submitted
- 12 Apr 2021
- Last updated
- 17 Aug 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Estevao C, Baldellou Lopez M, Davis RE, Jarret L, Soukup T, Bakolis I, Healey A, Harrington J, Woods A, Crane N, Jones F, Pariante C, Fancourt D, Sevdalis N. Evaluation of a community-based performance arts programme for people who have experienced stroke in the UK: protocol for the SHAPER-Stroke Odysseys study. BMJ Open. 2022 Mar 11;12(3):e057805. doi: 10.1136/bmjopen-2021-057805.
PubMed 35277410
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Stroke Odysseys: Evaluation of a Community-based Performance Arts Programme for People That Have Experienced Stroke
- ClinicalTrials.gov ID
- NCT04864470
- Acronym / sponsor ID
- SHAPER-SO / 219425/Z/19/Z-SO
- Conditions
- Stroke
- Keywords
- Stroke, Health-arts intervention, Performing arts
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 122 participants (estimated)
- Lead sponsor
- King's College LondonUniversity, hospital or other
- Collaborators
- Rosetta Life, Kingston University and St George's
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 1 Nov 2022 (estimated)
- Study completion
- 1 Nov 2022 (estimated)
- First posted
- 29 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
There are over 1.2 million stroke survivors in the UK and annual costs of stroke care to the NHS will treble from £3.4 billion in 2015 to £10.2 billion in 2035. More than 60% of stroke survivors leave hospital with a disability, and half experience depression within the first five years. Emotional, social and psychological needs are common, often compounded by patients' perceptions of 'abandonment' when rehabilitation ends.
Currently there is a gap between the social, emotional and physical needs of stroke survivors and the availability and suitability of long-term recovery and rehabilitation services. In 2018, a commissioned survey by the Stroke Association found 50% of stroke survivors and 85% of carers felt they needed more support than currently exists.
Stroke Odysseys - the performance art programme- provides an opportunity for communication of experiences of stroke to an audience through acquired skills in movement, music, song and the spoken word. The performance arts courses delivered by Rosetta Life for stroke survivors have been evaluated in previous studies and have shown that engagement in and learning about performance skills can have a positive impact on perceptions of disability, improve cognition, mobility and speech disabilities among a stroke community that can be stigmatised by the public perception of disabling illness.
The Stroke Odysseys programme will be scaled up to a large number of participants with the aim to evaluate the experience, impact and implementation of the programme. This prospective study will evaluate the experience and impact of Stroke Odysseys on those participating using mixed methods (interviews, observations and surveys) prior to and after each stage of the programme, and carry out non-participant observations during a percentage of the workshops, training and tour.
This trial will also examine how effectively the programme is implemented and the factors (facilitators or barriers) that affect its implementation (i.e. implementation effectiveness). This will help us to identify not just 'if' but also 'why' the programme works and support our understanding of how it can be successfully delivered and scaled up within clinical pathways. Within this, the researchers will also explore the cost effectiveness of the programme, including the cost of its delivery and the balance of the benefit for the health sector, in order to be able to develop strong business plan for its longer-term use and wider scale implementation.
Detailed description
There are over 1.2 million stroke survivors in the UK and annual costs of stroke care to the NHS will treble from £3.4 billion in 2015 to £10.2 billion in 2035. More than 60% of stroke survivors leave hospital with a disability, and half experience depression within the first five years. Emotional, social and psychological needs are common, often compounded by patients' perceptions of 'abandonment' when rehabilitation ends. The impact also extends to family caregivers who experience higher rates of depression than the general population. This issue is a clear research finding expressed in numerous systematic reviews, including a meta-review by Pearce et al 2015. The review team highlighted: "The devastating impact of stroke on patients' self-image; the varying needs for self-management support across the trajectory of recovery; the need for psychological and emotional support throughout recovery particularly when physical recovery plateaus; the considerable information needs of patients and carers which also vary across the trajectory of recovery; the importance of good patient-professional communication; the potential benefits of goal-setting and action-planning; and the need for social support which might be met by groups for stroke survivors".
Currently there is a gap between the social, emotional and physical needs of stroke survivors and the availability and suitability of long-term recovery and rehabilitation services. In 2018, a commissioned survey by the Stroke Association also confirmed the devastating impact of stroke on the lives of individuals and their carers. Responses from more than 11,000 stroke survivors and carers showed a range of 'hidden effects', which do not necessarily disappear with time, and in many cases, can be life-long. Most common were the effect on emotional and mental health, cognition, confidence, finances, social life and relationships. The survey findings also showed 50% of stroke survivors and 85% of carers felt they needed more support than currently exists.
Stroke Odysseys - the performance art programme- provides an opportunity for communication of experiences of stroke to an audience through acquired skills in movement, music, song and the spoken word. The Stroke Odysseys approach has been developed over a number of years and is facilitated by the charity Rosetta Life, with a track record of in hospital, hospice and community-based performance arts projects. This program aims to address the sense of abandonment and social isolation experienced by stroke survivors after statutory care (community rehabilitation) is completed. The performance arts courses delivered by Rosetta Life for stroke survivors have been evaluated in previous studies and have shown that engagement in and learning about performance skills can have a positive impact on perceptions of disability, improve cognition, mobility and speech disabilities among a stroke community that can be stigmatised by the public perception of disabling illness.
Trial design and aims: The Stroke Odysseys programme will be scaled up to a large number of participants with the aim to evaluate the experience, impact and implementation of the programme. Evaluation will take place across community settings in South London and involve stroke participants and the wider stakeholder community.
Stroke Odysseys comprises three distinct stages:
- weekly workshops over 12 weeks for stroke participants facilitated by an integrated team of expert artists and ambassadors from the charity Rosetta Life
- a smaller group of ambassadors recruited from the workshops will be trained to become co-facilitators (stroke ambassadors)
- a performance tour including education and taster workshops for audiences.
The project will evaluate the experience and impact of Stroke Odysseys on those participating using mixed methods (interviews, observations and surveys) prior to and after each stage, and carry out non-participant observations during a percentage of the workshops, training and tour.
Pandemic (COVID-19) Response: Depending on government guidelines on social distancing and foreseeing increased anxiety in stroke survivors to attend in-person sessions, the programme stages will be delivered using a blended approach of small in-person sessions and online live-streamed sessions. Participants will self-select, according to their willingness to travel and to meet socially with others. Those who choose to come to a studio will be invited to do so and those who choose to join from home will participate online. A researcher will manage groups to ensure that all the participants that wish to attend in person will be able to do so during the 12-weeks.
This is a prospective mixed methods study using a range of qualitative and quantitative methods at different time points pre, during and post implementation of each programme cycle. The research will want to understand the impact of Stroke Odysseys on improving patients' symptoms and their emotional wellbeing i.e.the effectiveness of the programme (i.e. intervention effectiveness). Additionally, and simultaneously, to examine how effectively the programme is implemented and the factors (facilitators or barriers) that affect its implementation (i.e. implementation effectiveness). This will help us to identify not just 'if' but also 'why' the programme works and support our understanding of how it can be successfully delivered and scaled up within clinical pathways. Within this, the research will also explore the cost effectiveness of the programme, including the cost of its delivery and the balance of the benefit for the health sector, in order to be able to develop strong business plan for its longer-term use and wider scale implementation.
An ethnographic and constructivist approach will be used to examine stroke survivors' experiences of the SO programme as it provides rich, holistic insights into people's views and actions, as well as the nature of the location (context) they inhabit, and this approach aligns well with the complex nature of the Stroke Odysseys programme.
Participants and Recruitment process: 75 new stroke survivors in total for the duration of the study. Based on previous experience of running Stroke Odysseys, a drop-out rate of 20% is expected and so the final number of ambassadors is estimated to be 60. Potential stroke survivor participants will be identified through signposting in community centres, care homes and the engagement offered through the presentations and screenings and taster sessions and performances from the performance tour. In response to the current pandemic, all recruitment will be delivered online.
In addition, a group of wider stakeholders will be recruited from the network of people involved in the referral, delivery or supporting of the programme. The wider stakeholders will be recruited from the network of people involved in the programme present in community. This includes the voluntary sector, health and social care sectors and clinical commissioners. A total of 47 stakeholders will be recruited for the stakeholder group.
Measures collected: There will be at 4 time points for data collection, run in two cycles in total (i.e. we will collect data twice at each timepoint, once for cycle one and then again for cycle 2).
T0 - Baseline pre-performance programme,
T1 - Midway through the programme
T2 - Immediately post performance
T3 - Immediately after the advocacy training for ambassadors
To maximise inclusivity and outcome completion, and to minimise participant burden, outcome assessments, where possible will be conducted either face-to-face, online, by telephone or via postal questionnaire depending on the outcome measures being assessed and participants preferences (and government COVID-19 guidelines).
To measure clinical outcomes, a mixture of qualitative and quantitative measures will be used:
Qualitative assessments (ethnographic research) Ethnographic non-participant observations of a selection of the 12 workshops including at least 1-2 groups from each of the two phases (building confidence, rehearsal and production) to capture facilitator and participant practice, interactions and routines. Each observation period will last for the duration of the workshop, and the researcher will record field-notes contemporaneously.
Implementation outcomes will also be assessed using a mixture of quantitative and qualitative measures.
Validated and standardised implementation scales will be used to gather quantitative data on how acceptable, appropriate and feasible the SO programme is perceived by stroke survivors, ambassadors, deliverers, supporters and referrers. These scales include:
- Acceptability of Intervention Measure (AIM): this is a 4-item scale that assesses how agreeable the programme is to participants.
- Intervention Appropriateness Measure (IAM): this is a 4-item scale that assesses how suitable participants find the programme.
- Feasibility of Intervention Measure (FIM): this is a 4-item scale that assesses how feasible to receive/deliver participants find the programme.
All 3 scales will be administered to the stroke survivors who have enrolled in the SO programme and given their consent for data collection (anticipated number = 75 participants) at 3 time points (T1-midway through the 12-week SO programme); T2 at the end of the SO programme; T3 at the end of the 4-week stroke ambassadors training). The researchers expect a drop-out rate of 20% for participants between stage one (12-week programme) and stage two (4-week ambassador training programme) which would leave approximately 60 participants completing the questionnaires at the end of stage two (T3). The investigators will also administer the scales to the wider stakeholder group comprising supporters, deliverers and referrers at timepoints T2 and T3 (approximately 20 participants in total).
The investigators also will conduct semi-structured interviews with a purposive sub-sample of stroke survivors (N= 20: 5 from each cycle at two time points - T2 and T3) to explore their attitudes towards the acceptability, appropriateness and feasibility of the programme, as well as factors (facilitators or barriers) that affected their involvement (and potential drop-out) and any unintended consequences. The research team will also explore these issues with a sub-sample of individuals from each of the wider stakeholder groups (10 in total). Views from individuals that are part of the wider stakeholder group will also be sought on factors that could affect the sustained use of the programme and strategies that were employed to implement the programme.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: Stroke OdysseysStroke Odysseys is a performing arts intervention for people who have had strokes which provides an opportunity for communication of experiences of stroke to an audience through acquired skills in movement, music, song and the spoken word. Stroke Odysseys comprises three distinct stages: 1. weekly workshops over 12 weeks for stroke participants facilitated by an integrated team of expert artists and ambassadors from the charity Rosetta Life 2. a smaller group of ambassadors recruited from the workshops will be trained to become co-facilitators (stroke ambassadors) 3. a performance tour including education and taster workshops for audiences. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- over 18 years of age
- have had one or more stroke(s)
- received inpatient care in a UK stroke care pathway and are able to follow a 2-stage command and hold a conversation in English if no supporter/friend is available to translate
Key exclusion criteria (3 listed)
- any person with co-morbidities that would prevent participation in group activities e.g. dementia or deteriorating or fluctuating palliative conditions
- unable to understand English
- unable to commit to the 12-week programme
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stroke OdysseysThe participants will take part in a twelve-week performance programme that takes place online/in a community halls/arts centre. Sessions run for three hours and during these sessions, participants devise a dance and music performance work from their own stories. The culmination of the programme will be a public facing performance to an audience of carers, health care practitioners, friends, family and the wider community, done online through Zoom. After the performance is completed, participants will be invited to a training programme where they learn to act as advocates for life after stroke - termed 'stroke ambassadors'. The training will be a four-day programme. The programme will take place once weekly and is led by a team of artists supported by a leadership coach, on Zoom. Following training, ambassadors will support artists in recruitment, befriend the newly discharged stroke survivors and take part in small scale performance tours to challenge the perception of disability. | Behavioural | Intervention |
Primary outcome
To evaluate emotional wellbeing, participation and activity of stroke participants and any change pre and post SO programme using qualitative methods
Time frame: The primary clinical outcome are qualitative changes in emotional wellbeing, participation and activity of stroke participants pre and post intervention (after 16 weeks)
To evaluate emotional wellbeing, participation and activity of stroke participants and any change pre and post intervention - ethnographic research and interviews
To evaluate to what extent Stroke Odysseys is acceptable, to survivors and wider stakeholders using the Acceptability of Intervention Measure (AIM)
Time frame: The AIM will be collected during the workshop (Week 6), after the workshop is completed (Week 12) and after stroke ambassador training (Week 16). Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16).
The primary outcome implementation measure is acceptability as measured by the Acceptability of Intervention Measure (AIM) A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean.
To evaluate to what extent Stroke Odysseys is acceptable, to survivors and wider stakeholders using semi-structured interviews.
Time frame: Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16).
The primary outcome implementation measure is acceptability as measured by semi-structured interviews to explore reasons for acceptability.
12 secondary outcomes
To study the context, mechanisms and interactions which take place during Stroke Odysseys delivery
Time frame: During workshop delivery (Week 6)
To explore learning and experiences of facilitators and participants
Time frame: After the workshop is completed (Week 12)
To explore stroke survivors' preparation and participation in performances
Time frame: Baseline
To evaluate to what extent Stroke Odysseys is appropriate to survivors and wider stakeholders
Time frame: The IAM will be collected during the workshop (Week 6), after the workshop is completed (Week 12) and after stroke ambassador training (Week 16). Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16)..
To evaluate to what extent Stroke Odysseys feasible to survivors and wider stakeholders
Time frame: The FIM will be collected during the workshop (Week 6), after the workshop is completed (Week 12) and after stroke ambassador training (Week 16). Interviews will be conducted after the workshop (Week 12) and after stroke ambassador training (Week 16).
To assess any unintended consequences of the programme
Time frame: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To explore the facilitators and barriers to implementing the programme
Time frame: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To explore the facilitators and barriers to sustained use of the programme
Time frame: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To assess service utilisation and cost associated costs and changes in quality of life associated with the implementation of the programme
Time frame: These measures will be collected after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To explore the strategies including resource inputs utilised, used within individual sites to implement the programme
Time frame: Interviews will be conducted after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To assess the adoption of the programme
Time frame: This will be measured at baseline, after completion of the workshop (Week 12) and after completion of stroke ambassador training (Week 16).
To assess programme adherence and attrition rates
Time frame: Data recorded from register on weekly attendance rates for 12-week programme (stage 1) and for 4-week ambassador programme (stage 2)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2022.
- Derived from this study: PubMed 35277410Estevao C, Baldellou Lopez M, Davis RE, Jarret L, Soukup T, Bakolis I, Healey A, Harrington J, Woods A, Crane N, Jones F, Pariante C, Fancourt D, Sevdalis N. Evaluation of a community-based performance arts programme for people who have experienced stroke in the UK: protocol for the SHAPER-Stroke Odysseys study. BMJ Open. 2022 Mar 11;12(3):e057805. doi: 10.1136/bmjopen-2021-057805.
Related trials for Stroke
Not yet recruiting
Brain-Machine Interface With Virtual Reality and Neuromuscular Electrical Stimulation for Upper Limb Rehabilitation After Stroke
Ischemic Stroke
Recruiting
Understanding and Enhancing Human Health and Movement
Spinal Cord Injury, Stroke (CVA) or Transient Ischemic Attack
Not yet recruitingObservational study
Detecting and Predicting Post-stroke Cognitive Impairment Using the Oxford Cognitive Screen
Stroke, Ischemic Stroke
Not yet recruitingObservational study
Integrating Wearable Monitoring and Clinical Data for Stroke Early Warning
Stroke, Ischemic Stroke
RecruitingObservational study
Stroke Hemiplegic Shoulder Pain: Ultrasound Findings and VAS (Cross-Sectional)
Hemiplegic Shoulder Pain, Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Institute of Psychiatry, Psychology & Neuroscience
London, United Kingdom
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Stroke Odysseys in people with Stroke, run by King's College London at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate emotional wellbeing, participation and activity of stroke participants and any change pre and post SO programme using qualitative methods (time frame: The primary clinical outcome are qualitative changes in emotional wellbeing, participation and activity of stroke participants pre and post intervention (after 16 weeks)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04864470, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2022.